U

Ulisse Biomed
UBM

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€20.32M
EV
€19.15M
Shares Outstanding
24.48M
Beta
0.74

Wall Street View

Analyst Rating
BUY
Analyst Target Price
€1.01
P/E 2025E
-
P/Revenue 2025E
12.76x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Ulisse Biomed S.p.A.

gainify

U

Ulisse Biomed S.p.A.

UBM

Ulisse Biomed S.p.A., a healthcare biotech company, develops, produces, and markets vitro diagnostic medical devices in Italy. The company through its Sagitta platform offers various tests, such as Ladymed/HPV Selfy for the detection of human papillomavirus (HPV); Cor...

Sector

Healthcare

Industry

Biotechnology

CEO

Basile, Nicola

Employees

22

IPO Date

2021-08-09

Headquarters

Via Cavour, 20, Udine, Udine, 33100, Italy

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.